Outsmarting Cancer, One Patient At A Time

Ironwood Women’s Centers and Ironwood Cancer & Research Centers are committed to the advancement of medical knowledge and patient care. Medical research has and continues to transform the practice of medicine resulting in a high quality of care we enjoy today. We believe that by supporting clinical research today, we are helping build the future of medicine and the profound developments that are sure to come. We have an active and expanding clinical research program.

We have a comprehensive team of physician investigators, research nurses, clinical research coordinators, research assistants and regulatory specialist serving all our offices. This allows us to provide the option for our eligible patients to the latest therapies and treatments.  If you are interested in participating in a clinical trial, please talk to your physician or call our research department at 480-398-7671.

Current Studies at Ironwood Cancer & Research Centers:

  • Previously treated metastatic HER2+Breast Cancer

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer (SOPHIA)
New sub-study includes margetuximab plus chemotherapy with decreased infusion time.

  • Previously treated Hormone receptor-positive, HER2 negative metastatic breast cancer whose disease progressed after prior systemic therapy

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer (SHERBOC)

Our Research Staff:

Principal Investigators Mikhail Shtivelband, MD, Ph.D. and Sujith Kalmadi, MD, oversee sub-investigators participating in trials that involve Ironwood Women’s Centers and Ironwood Cancer & Research Centers.  For a list of our closed studies click here.